piperacillin has been researched along with Burns in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 5 (27.78) | 18.2507 |
2000's | 2 (11.11) | 29.6817 |
2010's | 9 (50.00) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S | 1 |
Laramie, KE; Miller, MA; Mueller, SW; Roper, SE; Torian, SC; Wiktor, AJ | 1 |
Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
Bathoorn, E; Beerthuizen, GIJM; Friedrich, AW; Kooistra-Smid, AMD; Nieuwenhuis, MK; Pirii, LE; Rossen, JWA; Vogels, W | 1 |
Branski, LK; Cambiaso-Daniel, J; Capek, KD; De Crescenzo, A; Finnerty, CC; Herndon, DN; Hundeshagen, G; Killion, EA; Kinsky, MP; Mlcak, RP; Norbury, WB; Sljivich, M; Voigt, CD | 1 |
Ben Khalifa, S; Daiki, M; Fekih Hassen, A | 1 |
Kalousis, K; Liodaki, E; Mailänder, P; Schopp, BE; Stang, F | 1 |
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M | 1 |
Han, S; Hong, T; Jeon, S; Lee, J; Paek, J; Woo, H; Yim, DS | 1 |
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
Deng, S; Han, C; Li, X; Liao, Z; Wang, W; Xu, W | 1 |
Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B | 1 |
Bourget, P; Carsin, H; Le Bever, H; Le Reveillé, R; Lesne-Hulin, A | 1 |
Heggers, JP; Herndon, DN; Villarreal, C; Walton, MA | 1 |
Mokaddas, E; Rotimi, VO; Sanyal, SC | 1 |
Zhang, YP | 1 |
Ackerman, BH; Cerra, FB; Shikuma, LR; Solem, LD; Strate, RG; Weaver, RH; Zaske, DE | 1 |
Fox, CL; Modak, S | 1 |
2 trial(s) available for piperacillin and Burns
Article | Year |
---|---|
[A multicenter clinical trial of piperacillin/tazobactam in burn infection].
Topics: Adult; Burns; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Treatment Outcome | 2002 |
Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.
Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Burns; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam | 1996 |
16 other study(ies) available for piperacillin and Burns
Article | Year |
---|---|
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2010 |
Burn Injury and Augmented Renal Clearance: A Case for Optimized Piperacillin-Tazobactam Dosing.
Topics: Anti-Bacterial Agents; Burns; Critical Illness; Humans; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam | 2023 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
Extensive colonization with carbapenemase-producing microorganisms in Romanian burn patients: infectious consequences from the Colectiv fire disaster.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Colistin; Disasters; Enterobacter cloacae; Humans; Kanamycin; Klebsiella pneumoniae; Linezolid; Microbial Sensitivity Tests; Netherlands; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Providencia; Pseudomonas aeruginosa; Romania; Silver Sulfadiazine | 2018 |
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients.
Topics: Acute Kidney Injury; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Cohort Studies; Creatinine; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Incidence; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Texas; Vancomycin | 2017 |
Epidemiological and bacteriological profiles in children with burns.
Topics: Anti-Bacterial Agents; Burns; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Oxacillin; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2014 |
Prophylactic antibiotic therapy after inhalation injury.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Burn Units; Burns; Burns, Inhalation; Case-Control Studies; Female; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Tracheostomy; Young Adult | 2014 |
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2014 |
Population pharmacokinetic analysis of piperacillin in burn patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Burns; Computer Simulation; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult | 2014 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2007 |
The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Aztreonam; Burns; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Monobactams; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome; Wound Infection | 1997 |
In vitro activity of piperacillin/tazobactam versus other broad-spectrum antibiotics against nosocomial gram-negative pathogens isolated from burn patients.
Topics: Burns; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 1998 |
[Common pathogens in burn infection and changes in their drug sensitivity].
Topics: Amikacin; Burns; Ciprofloxacin; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Proteus; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 1991 |
Thermal injury effects on drug disposition: a prospective study with piperacillin.
Topics: Adult; Biological Availability; Burns; Drug Administration Schedule; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Piperacillin; Prospective Studies; Random Allocation; Time Factors | 1990 |
Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections.
Topics: Administration, Topical; Animals; Burns; Culture Media; Drug Synergism; Female; Mice; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Silver Sulfadiazine; Sulfadiazine; Wound Infection | 1985 |